Earnings Review · 23 October 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
How the market took it
On 2026-10-23 the shares closed at $16.14, +4.3% against the prior close of $15.47 (opening +6.1% from the prior close). Sellers faded the pop: 1.8 points of the opening gain were given back by the close, which says the first read was too generous.
Did the flow confirm the move?
Underlying money flow is neutral (21-day Chaikin Money Flow -0.04, five-day price change -0.1%, as of 2026-10-22, desk flow model): no strong accumulation or distribution signature.
Give the business its due
The business itself is genuinely strong: revenue growing about 1%, net margins near 2%, a weak competitive moat, backed by a 3% return on equity.
Levels that matter
At $16.14 the shares sit 24% below the 52-week high of $21.23 and 9% above the low of $14.79 (21% of the way up the range). The 50-day average is $16.75, above the price. The 200-day average is $18.04, above the price.
The valuation lens
The shares trade about 11% above our fair-value estimate: priced for things to go right. Fair value lands near $15 against a $16.14 share price, a margin of safety of about -11%. The trailing multiple sits around 86 times earnings, which only makes sense if the growth holds.
The ethical lens, our differentiator
Screens compliant (both standards agree). A name values-conscious investors can weigh on the merits.
The verdict for a values-conscious investor
It clears the screen; size it to your own risk and conviction. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.
